btp-114
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02950064)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- DNACROSS-LINKING AGENT
DNA cross-linking agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- btp-114
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02950064 | Phase 1 | Sep 1, 2016 | Placon Therapeutics, Tennessee Oncology, PLLC |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Placon Therapeutics | For profit | 1 | 1 | 1 | 2016 |
| Tennessee Oncology, PLLC | Academic/Hospital | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1